Martin Lehr

Martin Lehr, Co-Founder & CEO of Context Therapeutics, discusses his transition from venture capitalist to startup CEO in the field of gynecological cancer therapies. Topics covered include their clinical trial approach, manufacturing process, and the challenges of transitioning from small molecules to bi-specific antibodies. The chapter also explores the benefits of investigator sponsored trials and collaborations with academic institutions.